La3+/Sr2+ Dual-Substituted Hydroxyapatite Nanoparticles as Bone Substitutes: Synthesis, Characterization, In Vitro Bioactivity and Cytocompatibility.

The present study aims to synthesize biocompatible and bioactive lanthanum (La3+)/strontium (Sr2+) dual ion doped hydroxyapatite (HA) nanomaterials by sol-gel method. The discrete substitution of La3+ and Sr2+ in pure HA enhances the osteoconductivity. The co-substitution of various La3+ concentrations (0.03, 0.06 and 0.1 M) regulates the physical and In Vitro properties. The study also investigates the effect of La3+/Sr2+ substituents on the crystalline property, microstructure, photoluminescence and In Vitro bioactivity of HA samples. La3+/Sr2+ co-substitution decreases the crystallite size of HA without any significant distortion of the crystal structure. In addition, the dual ions doping influences nanoparticles morphology by reducing the particle size from 75 to 20 nm. The In Vitro bioactivity tests for the La3+/Sr2+ co-substituted HA confirm the osteoconductive boneapatite generating capacity. Bactericidal tests against Staphylococcus aureus and Pseudomonas aeruginosa stains show better resistivity of La3+/Sr2+-HA samples. To authenticate the biocompatibility and antimicrobial activity of the synthesized La3+/Sr2+ dual doped HA nanoparticles for bone implant applications, different tests like cell viability and toxicity were conducted using human lung A549 cells.

In-vitro biocompatibility, bioactivity and photoluminescence properties of Eu3+ /Sr2+ dual-doped nano-hydroxyapatite for biomedical applications.

In the present investigation, we have successfully synthesized luminescent Eu3+ -doped and Eu3+ /Sr2+ codoped hydroxyapatite (HA) nanoparticles through sol-gel assisted precipitation method with the aim of developing novel biomaterials containing osteoblast mineral (Sr2+ ) and luminescence activator (Eu3+ ). The structure, morphology, thermal stability, and luminescence properties of the resultant spherical nanoparticles (50-100 nm diameters) were studied. Moreover, the in-vitro bioactivity of Eu0.1 Sr0.1 HA nanoparticles was investigated by immersing in the simulated body fluid for many weeks. The antimicrobial activity results against gram positive and gram negative bacterial stains, showed better resistivity for the Eu0.1 Sr0.1 HA among the other compositions. The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay of live/dead cells cultured with Eu3+ /Sr2+ -doped HA nanoparticles retained its normal morphology and did not show a significant impact on cell proliferation at various incubation days, which evidence for the material's superior biocompatible nature even at a higher concentration of 375 µg/mL. Thus, the incorporation of dual ions in HA nanoparticles with strong luminescence properties develops potential biomaterial for live cell imaging and in nanomedicine. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 2191-2201, 2018.